Start here: which GLP-1 question are you actually asking?

Almost everything written about these drugs answers a question slightly to the left of the one people arrive with. The list below is the set of questions this site is organised around. Pick the one that is actually yours; each row goes to the page that answers it and to the page most people need next.

Four facts that change most decisions

• ◆The advertised price is usually the starting-dose price. Every product in this class climbs a dose ladder over roughly four months, and the dose you stay on is rarely the dose in the advert — Every dose step, and what to do when you miss one.
• ◆Stopping brings the weight back. Trial extensions and a systematic review of 37 studies agree. That makes the monthly figure a standing cost rather than the price of a course — What happens when you stop.
• ◆One molecule is sold under several brands at very different prices, and the diabetes brands say on their own sites that they are not weight-loss drugs — Same molecule, different label, ten times the price and Every GLP-1 brand, and what each one is licensed for.
• ◆Most services do not publish most of what you would want to know. Across the 87 reviewed here, the mean service answers 7.6 of thirteen standard questions, and none answers all thirteen — Thirteen things a GLP-1 service should tell you before you pay.

What this site is, in one paragraph

Every factual claim in the 87 provider reviews traces to a URL listed on the page and retrieved on the date recorded. Where a company blocks retrieval, the review rests on a dated archive snapshot and says so at the top. Where nothing could be retrieved at all, no review is written and the gap is published instead. Derived claims — counts, shares, rankings — are computed from the data rather than asserted, so the copy cannot drift away from the reviews it summarises. The full reasoning is on the methodology page.

The whole map

If you would rather browse than be routed: the reviews index holds every researched provider, the best-of pages rank them on stated bases, the comparisons put products side by side, and the guides cover everything else. The medication pages sit behind Semaglutide, Tirzepatide, oral semaglutide, Orforglipron, Liraglutide and Dulaglutide, each with its trial cited.

And if you are already taking one of these and looking for something specific: side effects are in GLP-1 side effects, sorted by what to do about them, shipping and storage in Shipping, storage and what happens when the box is late, supplements marketed alongside them in GLP-1 supplements: what the label says, and what the evidence says, and the litigation reshaping the compounded tier in The drugmakers are suing your pharmacy.